Cargando…
Drug Delivery Nanosystems in Glioblastoma Multiforme Treatment: Current State of the Art
Glioblastoma multiforme (GBM) is the most common primary malignant Central Nervous System cancer, responsible for about 4% of all deaths associated with neoplasia, characterized as one of the fatal human cancers. Tumor resection does not possess curative character, thereby radio and/or chemotherapy...
Autores principales: | Di Filippo, Leonardo Delello, Duarte, Jonatas Lobato, Luiz, Marcela Tavares, de Araújo, Jennifer Thayanne Cavalcante, Chorilli, Marlus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8686306/ https://www.ncbi.nlm.nih.gov/pubmed/32867643 http://dx.doi.org/10.2174/1570159X18666200831160627 |
Ejemplares similares
-
Targeted Liposomes: A Nonviral Gene Delivery System for Cancer Therapy
por: Luiz, Marcela Tavares, et al.
Publicado: (2022) -
A receptor-mediated landscape of druggable and targeted nanomaterials for gliomas
por: Di Filippo, Leonardo Delello, et al.
Publicado: (2023) -
Delivery Strategies of Probiotics from Nano- and Microparticles: Trends in the Treatment of Inflammatory Bowel Disease—An Overview
por: Lopes, Sílvio André, et al.
Publicado: (2023) -
New Technological Approaches for Dental Caries Treatment: From Liquid Crystalline Systems to Nanocarriers
por: Luiz, Marcela Tavares, et al.
Publicado: (2023) -
Drug Delivery Nanosystems for the Localized Treatment of Glioblastoma Multiforme
por: Nam, L., et al.
Publicado: (2018)